These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 6115104

  • 1. Renal toxicity during therapy with gentamicin or tobramycin.
    Keys TF, Kurtz SB, Jones JD, Muller SM.
    Mayo Clin Proc; 1981 Sep; 56(9):556-9. PubMed ID: 6115104
    [Abstract] [Full Text] [Related]

  • 2. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ, Plaut ME, Cerra FB.
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [Abstract] [Full Text] [Related]

  • 3. Tobramycin and gentamicin are equally safe for neonates: results of a double-blind randomized trial with quantitative assessment of renal function.
    Itsarayoungyuen S, Riff L, Schauf V, Hamilton L, Otrembiak J, Vidyasagar D.
    Pediatr Pharmacol (New York); 1982 May; 2(2):143-55. PubMed ID: 12760406
    [Abstract] [Full Text] [Related]

  • 4. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA.
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [Abstract] [Full Text] [Related]

  • 5. The increase in urinary alanine aminopeptidase excretion associated with enflurane anesthesia is increased further by aminoglycosides.
    Motuz DJ, Watson WA, Barlow JC, Velasquez NV, Schentag JJ.
    Anesth Analg; 1988 Aug; 67(8):770-4. PubMed ID: 2899408
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR, Lipsky JJ, Laskin OL, Hellmann DB, Mellits ED, Longstreth J, Lietman PS.
    N Engl J Med; 1980 May 15; 302(20):1106-9. PubMed ID: 6988713
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO.
    J Infect Dis; 1978 May 15; 137 Suppl():S144-S149. PubMed ID: 349093
    [Abstract] [Full Text] [Related]

  • 8. Renoprotective role of nifedipine during gentamicin therapy: randomized controlled trial.
    Vlasic-Matas J, Rumboldt Z, Karelovic D.
    Croat Med J; 2000 Dec 15; 41(4):417-22. PubMed ID: 11063766
    [Abstract] [Full Text] [Related]

  • 9. Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy.
    Gluhovschi G, Gadalean F, Gluhovschi C, Velciov S, Petrica L, Bob F, Bozdog G, Kaycsa A.
    Ren Fail; 2014 May 15; 36(4):534-40. PubMed ID: 24456153
    [Abstract] [Full Text] [Related]

  • 10. The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis.
    Glass S, Plant ND, Spencer DA.
    J Cyst Fibros; 2005 Dec 15; 4(4):221-5. PubMed ID: 16239129
    [Abstract] [Full Text] [Related]

  • 11. A randomized, comparative study of tobramycin and gentamicin in treatment of acute urinary tract infections.
    Walker BD, Gentry LO.
    J Infect Dis; 1976 Aug 15; 134 Suppl():S146-9. PubMed ID: 787449
    [Abstract] [Full Text] [Related]

  • 12. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.
    Kumin GD.
    JAMA; 1980 Oct 17; 244(16):1808-10. PubMed ID: 7420681
    [Abstract] [Full Text] [Related]

  • 13. Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis.
    Gentry LO, Wood BA, Martin MD, Smythe J.
    Scand J Infect Dis Suppl; 1980 Oct 17; suppl 25():96-100. PubMed ID: 7010544
    [Abstract] [Full Text] [Related]

  • 14. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW.
    Clin Infect Dis; 2009 Mar 15; 48(6):713-21. PubMed ID: 19207079
    [Abstract] [Full Text] [Related]

  • 15. Renal toxicity of aminoglycosides in the neonatal period.
    Heimann G.
    Pediatr Pharmacol (New York); 1983 Mar 15; 3(3-4):251-7. PubMed ID: 6146123
    [Abstract] [Full Text] [Related]

  • 16. Renal toxicity. Tobramycin and gentamicin.
    Fry TL, Fried FA, Goven BA.
    Invest Urol; 1977 Sep 15; 15(2):100-3. PubMed ID: 903207
    [Abstract] [Full Text] [Related]

  • 17. Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.
    Kuhlmann J, Seidel G, Grötsch H.
    Infection; 1982 Sep 15; 10(4):233-9. PubMed ID: 6127319
    [Abstract] [Full Text] [Related]

  • 18. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C, Bosomworth M, Clifton I, Peckham DG, Conway SP.
    J Cyst Fibros; 2007 Jan 15; 6(1):67-73. PubMed ID: 16844430
    [Abstract] [Full Text] [Related]

  • 19. Gentamicin and tobramycin in patients with various infections--nephrotoxicity.
    Kahlmeter G, Hallberg T, Kamme C.
    J Antimicrob Chemother; 1978 May 15; 4 Suppl A():47-52. PubMed ID: 659349
    [No Abstract] [Full Text] [Related]

  • 20. Enzymuria in neonates during treatment with gentamicin or tobramycin.
    Tessin I, Trollfors B, Bergmark J, Jagenburg R, Hultberg B.
    Pediatr Infect Dis J; 1987 Sep 15; 6(9):870-1. PubMed ID: 2890136
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.